Hussman Strategic Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-6,200
| Closed | -$1.14M | – | 368 |
|
|
2021
Q2 | $1.14M | Sell |
6,200
-1,000
| -14% | -$184K | 0.24% | 163 |
|
|
2021
Q1 | $1.1M | Buy |
+7,200
| New | +$1.1M | 0.23% | 169 |
|
|
2020
Q3 | – | Sell |
-10,300
| Closed | -$1.16M | – | 322 |
|
|
2020
Q2 | $1.16M | Sell |
10,300
-200
| -2% | -$22.4K | 0.29% | 133 |
|
|
2020
Q1 | $943K | Hold |
10,500
| – | – | 0.25% | 158 |
|
|
2019
Q4 | $1.14M | Hold |
10,500
| – | – | 0.36% | 105 |
|
|
2019
Q3 | $1.03M | Buy |
10,500
+500
| +5% | +$49K | 0.29% | 127 |
|
|
2019
Q2 | $1.31M | Sell |
10,000
-10,000
| -50% | -$1.31M | 0.37% | 107 |
|
|
2019
Q1 | $2.7M | Hold |
20,000
| – | – | 0.66% | 47 |
|
|
2018
Q4 | $1.95M | Buy |
+20,000
| New | +$1.95M | 0.47% | 94 |
|